ICD-10 Code G30.1: Alzheimer’s Disease with Late Onset

Key Takeaways

ICD-10 Code G30.1 identifies Alzheimer’s disease with late onset, defined as symptom onset at age 65 or older.

G30.1 is never billed alone for dementia; a secondary F02.xx code is always required under the etiology/manifestation convention.

G30.1 must be sequenced first as the etiology, followed by the appropriate F02 code capturing dementia severity and any behavioral disturbance.

Pabau’s claims management software helps memory care and neurology practices apply dual-code sequencing and reduce claim denials.

Late-onset Alzheimer’s is the most common form of dementia in the United States, yet it generates a disproportionately high volume of coding denials. The reason is almost always the same: coders submit ICD-10 Code G30.1 without the required secondary F02 manifestation code, or they sequence the pair in the wrong order. Either error is enough for a payer to reject the claim outright. This reference covers the code’s definition, billability, mandatory dual-code pairing, sequencing rules, documentation requirements, and the most common audit triggers – so your practice applies ICD-10 Code G30.1 correctly every time.

ICD-10-CM is maintained jointly by the Centers for Medicare and Medicaid Services (CMS) and the National Center for Health Statistics (NCHS). FY2026 codes are valid for HIPAA-covered transactions from October 1, 2025 through September 30, 2026.

ICD-10 Code G30.1: Definition and Clinical Overview

ICD-10 Code G30.1 is a billable ICD-10-CM diagnosis code for Alzheimer’s disease with late onset. It falls under category G30 (Alzheimer’s disease) within the chapter covering “Other degenerative diseases of the nervous system” (G30-G32). The CDC/NCHS ICD-10-CM web tool confirms G30.1 as valid for FY2026.

Late onset refers to symptom onset at age 65 or older. This age threshold is the key clinical distinction between G30.1 and G30.0 (early onset, also called presenile dementia, where symptoms appear before age 65). Importantly, classification is based on the age at which symptoms first appeared – not the age at formal diagnosis. A patient diagnosed at 72 who experienced cognitive decline beginning at 68 is correctly coded as G30.1.

Alzheimer’s disease is a progressive neurodegenerative condition. It causes cortical atrophy, neurofibrillary tangles, and amyloid plaques that disrupt memory, reasoning, language, and eventually the ability to perform daily tasks. The ICD-10-CM system treats dementia as an inherent manifestation of Alzheimer’s disease, which drives the dual-code requirement discussed in the next section.

G30.1 Billable Status and Code Validity

G30.1 is a valid, billable ICD-10-CM code for FY2026. However, it is not a standalone claim code when dementia is documented. Per ICD-10-CM coding convention, G30.1 must always be accompanied by a secondary F02.xx code. Submitting G30.1 alone on a claim where dementia is the presenting concern is a coding error and will attract denial or audit scrutiny.

• Code set: ICD-10-CM (US-specific; the international WHO ICD-10 version uses F00 for Alzheimer’s dementia)
• Category: G30 – Alzheimer’s disease
• Valid period: October 1, 2025 – September 30, 2026 (FY2026)
• Requires secondary code: Yes – always paired with F02.xx
• Sequencing position: First (etiology); F02.xx follows as manifestation

Etiology/Manifestation Convention: G30.1 and F02 Codes

The etiology/manifestation convention is one of ICD-10-CM’s most important sequencing rules, and Alzheimer’s disease is a textbook example of how it works. Certain conditions produce both an underlying disease (the etiology) and distinct manifestations that affect other body systems. ICD-10-CM requires both to be coded – and in a specific order.

For Alzheimer’s coding, G30.1 is the etiology code (the underlying disease). The F02 category captures the dementia manifestation – its severity, behavioral features, and functional impact. The ICD-10-CM Tabular List includes a “use additional code” instruction at G30.1, and a “code first” instruction at F02.xx, directing coders to sequence G30.1 before any F02 code. This is confirmed across the WHO ICD-10 browser and official CMS coding guidelines.

F02 Subcategory Selection

Choosing the correct F02 subcategory is not optional – it requires documented clinical evidence. As of FY2024 (October 1, 2023), ICD-10-CM expanded the F02 category significantly. F02.81 (dementia with behavioral disturbance) is no longer billable as a standalone code – it was converted to a non-billable parent and must be further specified to F02.811 (with agitation) or F02.818 (with other behavioral disturbance). The F02 category now requires specifiers for both severity and behavioral/psychiatric features.

Unspecified severity (F02.8x): Use when the provider documents dementia without specifying severity. F02.80 covers dementia without behavioral disturbance, psychotic disturbance, mood disturbance, or anxiety. F02.811 covers dementia with agitation. F02.818 covers dementia with other behavioral disturbance. F02.82 covers dementia with psychotic disturbance. F02.83 covers dementia with mood disturbance. F02.84 covers dementia with anxiety.

Severity-stratified codes: When severity is documented, use the corresponding series: F02.A (mild), F02.B (moderate), or F02.C (severe). Each has the same specifier structure – e.g., F02.A0 (mild, without disturbance), F02.A11 (mild, with agitation), F02.B3 (moderate, with mood disturbance), F02.C0 (severe, without disturbance).

When behavioral, psychotic, mood, or anxiety features are documented, the corresponding specifier code is required – coders may not default to F02.80 for convenience. Each feature must be explicitly described in the clinical record. Vague language such as “patient seems agitated” does not meet the specificity bar most payers expect. The note should describe the behavior, its frequency, and its clinical impact. Note that F02.81 itself is no longer billable – use F02.811 (agitation) or F02.818 (other behavioral disturbance) instead. Practices using claims management software with coding audit features can flag invalid F02.81 submissions and prompt the correct specifier before claim submission.

G30.1 vs G30.0: Distinguishing Early and Late Onset

The G30 category contains four codes, and choosing between G30.0 and G30.1 is the most clinically significant decision a coder makes in Alzheimer’s documentation. Selecting the wrong code based on age at diagnosis rather than age at symptom onset is the most common specificity error in this code set. Our separate reference for G30.9 (Alzheimer’s disease, unspecified) covers the broader G30 category in detail.

• G30.0 – Alzheimer’s disease with early onset: Symptom onset before age 65; also referred to as presenile dementia. Rarer, often with genetic components (e.g., PSEN1/PSEN2 mutations).
• G30.1 – Alzheimer’s disease with late onset: Symptom onset at age 65 or older. The most prevalent form, accounting for the majority of Alzheimer’s diagnoses.
• G30.8 – Other Alzheimer’s disease: Reserved for atypical or less clearly classified Alzheimer’s variants.
• G30.9 – Alzheimer’s disease, unspecified: A non-specific code; appropriate only when the clinical record does not document onset timing. Using G30.9 when G30.1 is supportable generates a specificity flag with many clearinghouses.

The AAPC Codify ICD-10-CM reference explicitly notes that classification depends on the age at symptom onset, not the age at diagnosis. When the clinical record does not specify onset age, the coder should query the treating provider before defaulting to G30.9. Most payers and clearinghouses will accept a provider attestation added as an addendum to the note. For practices managing neurological diagnosis documentation, psychiatry EMR software with structured intake templates can capture onset timing systematically at the point of evaluation.

Documentation Requirements for G30.1

Clean G30.1 coding depends entirely on what the clinical note contains. Payers auditing Alzheimer’s claims look for specific documentation elements that justify both the G30.1 etiology code and the selected F02 manifestation code. Missing any one of these elements creates a denial risk that cannot be corrected at the billing stage.

Required Documentation Elements

• Explicit Alzheimer’s diagnosis: The provider must use the term “Alzheimer’s disease” or “Alzheimer’s dementia.” Non-specific terms like “memory loss,” “cognitive impairment,” or “dementia NOS” do not support G30.1.
• Onset age or onset period: The note should document when cognitive symptoms first appeared. “Onset at age 67” or “symptoms began approximately five years ago when the patient was 71” are both acceptable. This establishes the late-onset classification.
• Dementia severity or staging: The clinical record should describe functional impact – activities of daily living, orientation, memory recall – to support the F02 code selection.
• Behavioral/psychiatric features (if F02.811, F02.818, F02.82, F02.83, or F02.84 is used): The specific feature – agitation, other behavioral disturbance, psychotic disturbance, mood disturbance, or anxiety – must be described with enough specificity to withstand audit review. F02.81 alone is no longer billable.
• Provider attestation of laterality or progression: For complex cases, documenting disease stage (mild, moderate, severe) strengthens the code assignment and reduces queries from clinical documentation improvement (CDI) teams.

Practices managing memory care patients benefit from structured clinical note templates that prompt providers to document each of these elements. Digital intake forms pre-populated with Alzheimer’s-specific fields – onset timing, behavioral observations, functional assessment scores – reduce the documentation gaps that generate CDI queries after the fact. Consistent documentation also supports compliance management across multi-provider practices where documentation quality can vary by clinician.

Related and Associated Codes

G30.1 rarely appears in isolation on a claim. Alzheimer’s patients often carry multiple comorbid diagnoses, and understanding which codes commonly pair with G30.1 helps coders sequence complex claim sets correctly. The AAPC Codify ICD-10-CM lookup provides a useful reference for exploring code relationships and excludes notes.

One area that trips up coders: the ICD-10-CM Tabular List includes Type 1 Excludes notes under G30 codes. These exclude codes for cerebrovascular disease sequelae (I69.01-I69.91) – meaning vascular cognitive decline must be coded separately and is not interchangeable with Alzheimer’s. For practices also handling neurological diagnoses like stroke, our reference on neurological diagnosis codes covers the relevant hemorrhage and cerebrovascular code set. Similarly, coders working across mental health and neurology may also encounter anxiety-adjacent diagnoses; the situational anxiety ICD-10 code guide covers F43 codes that sometimes appear alongside dementia on complex claims.

Reduce Alzheimer’s Coding Errors Before Claims Leave the Practice

Pabau's practice management platform supports accurate dual-code documentation for G30.1 claims, with structured clinical notes, digital intake forms, and integrated claims workflows that flag sequencing gaps before submission.

Book a demo

Common ICD-10 Code G30.1 Coding Errors and Audit Risks

Alzheimer’s coding errors tend to cluster around a small number of predictable mistakes. CMS and private payers flag these patterns through pre-payment edits, post-payment audits, and Recovery Audit Contractor (RAC) reviews. Identifying them before claims are submitted is far less costly than managing the appeal process after denial.

Most Frequent Errors

• Submitting G30.1 without F02.xx: The single most common error. G30.1 alone does not capture the dementia manifestation. Every claim coding Alzheimer’s disease in a patient with dementia must include a secondary F02 code.
• Incorrect sequencing (F02.xx before G30.1): The etiology/manifestation convention is explicit – G30.1 must be listed first. Reversing the order confuses payer systems and can trigger automatic denial flags.
• Using a disturbance specifier without documentation: Applying F02.811, F02.818, F02.82, F02.83, or F02.84 without supporting clinical notes creates an audit risk. The documentation must describe the specific feature – not just assert its presence. Also note that submitting F02.81 (now a non-billable parent) will trigger automatic rejection.
• Defaulting to G30.9 when G30.1 is supportable: When the record contains enough information to establish late onset, using G30.9 (unspecified) is a specificity error. Many clearinghouses generate a warning; some payers reject non-specific codes when specific alternatives are available.
• Onset age at diagnosis vs. onset age at symptom appearance: Classifying based on when the diagnosis was made, rather than when symptoms began, can result in G30.1 being assigned to patients who should carry G30.0.

Practices managing high volumes of memory care patients benefit from a mental health EMR that includes coding validation rules at the point of claim preparation. Automated sequencing checks that verify G30.1 precedes F02.xx, that F02.81 is flagged as non-billable, and that disturbance specifiers (F02.811, F02.818, F02.82-F02.84) are only selected when the corresponding feature is documented in the linked note, reduce the manual review burden on billing teams significantly.

EHR Workflow Considerations for G30.1 Documentation

The gap between a correct clinical assessment and a correctly coded claim often comes down to how well the EHR supports structured documentation. Alzheimer’s late-onset cases are longitudinal by nature – patients return repeatedly, their condition progresses, and the F02 code selection may need to change as behavioral disturbances emerge or severity worsens. An EHR that treats each encounter as isolated creates documentation silos that make accurate G30.1 coding harder over time.

Effective documentation workflows for G30.1 cases include several components. First, intake templates should capture symptom onset age explicitly – not just current age. Second, progress note templates should include a structured behavioral assessment section that prompts providers to address agitation, aggression, and psychotic features by name. Third, coding review should happen before submission rather than post-denial, with a checklist verifying that G30.1 appears first and that the F02 selection matches the documented clinical picture.

Practices using AI-assisted documentation tools can generate structured clinical notes that capture the elements payers look for, reducing the time providers spend on documentation while improving coding specificity. When combined with a dedicated client record system that tracks condition progression across encounters, the risk of F02 code drift – where the selected subcategory no longer matches the patient’s current clinical status – drops considerably. A well-maintained client record gives coders the longitudinal view they need to confirm that G30.1 + F02.81 is appropriate for a returning patient whose behavioral disturbance was not present at prior visits.

Expert Picks

Need a comprehensive psychiatry coding and documentation framework? Psychiatric Evaluation Template provides a structured approach to mental health assessments that supports accurate diagnosis coding.

Managing a neurology or memory care practice? Psychiatry EMR Software covers the workflow tools that support complex neurological and behavioral health documentation.

Looking for the G30 category overview? ICD-10 Code G30.9 covers the full G30 Alzheimer’s disease category, including the specificity hierarchy and when unspecified codes are appropriate.

Conclusion

ICD-10 Code G30.1 is one of the more nuanced codes in the neurological diagnostic set – not because the code itself is complex, but because its mandatory pairing with F02.xx, the strict sequencing requirement, and the documentation specificity needed for behavioral disturbance specifiers create multiple points where claims can go wrong. Getting the etiology/manifestation pair right, selecting F02.80 or F02.81 based on documented clinical evidence, and confirming late onset from symptom history rather than diagnosis date are the three practices that separate clean Alzheimer’s claims from repeated denials.

Pabau supports memory care and neurology practices with structured clinical documentation, integrated claims workflows, and claims management tools that flag dual-code sequencing gaps before submission. To see how Pabau handles Alzheimer’s and complex neurological coding workflows, book a demo with the team.

Frequently Asked Questions